scholarly article | Q13442814 |
P356 | DOI | 10.1126/SCISIGNAL.2003358 |
P698 | PubMed publication ID | 22827995 |
P2093 | author name string | Barbara A Osborne | |
Lisa M Minter | |||
P2860 | cites work | T cell activation | Q24658051 |
The Anti-apoptotic Effect of Notch-1 Requires p56 -dependent, Akt/PKB-mediated Signaling in T Cells | Q28212977 | ||
Notch signalling regulates stem cell numbers in vitro and in vivo | Q28248390 | ||
Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment | Q33652471 | ||
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. | Q34801853 | ||
Synergy between the ESCRT-III complex and Deltex defines a ligand-independent Notch signal | Q35621031 | ||
Notch signalling during peripheral T-cell activation and differentiation | Q36684906 | ||
Endocytic routes to Notch activation | Q37979555 | ||
Distinct spatial and molecular features of notch pathway assembly in regulatory T cells | Q39308967 | ||
A hierarchical cascade activated by non-canonical Notch signaling and the mTOR-Rictor complex regulates neglect-induced death in mammalian cells | Q39876274 | ||
Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways | Q42099912 | ||
Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia | Q42542192 | ||
P433 | issue | 234 | |
P304 | page(s) | pe31 | |
P577 | publication date | 2012-07-24 | |
P1433 | published in | Science Signaling | Q7433604 |
P1476 | title | Notch and the survival of regulatory T cells: location is everything! | |
P478 | volume | 5 |
Q34276546 | A functional interplay between 5-lipoxygenase and μ-calpain affects survival and cytokine profile of human Jurkat T lymphocyte exposed to simulated microgravity |
Q58572862 | Notch and NF-κB: Coach and Players of Regulatory T-Cell Response in Cancer |
Q34017104 | Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer |
Search more.